Description: Mayne Pharma Group Limited, a specialty pharmaceutical company, manufactures and sells branded and generic pharmaceutical products in Australia, New Zealand, the United States, Canada, Europe, Asia, and internationally. The company operates through three segments: Women's Health, Dermatology, and International. It provides oral drug delivery systems; and contract development and manufacturing services to third-party customers, as well as distributes specialty pharmaceutical products in the dermatology, women's health, and infectious disease therapeutic areas. The company was formerly known as Halcygen Pharmaceuticals Limited and changed its name to Mayne Pharma Group Limited in November 2010. Mayne Pharma Group Limited was incorporated in 2005 and is based in Salisbury South, Australia.
Home Page: www.maynepharma.com
1538 Main North Road
Salisbury South,
SA
5106
Australia
Phone:
61 8 8209 2666
Officers
| Name | Title |
|---|---|
| Mr. Shawn Patrick O'Brien B.Sc | CEO, MD & Director |
| Mr. Aaron Gray | Chief Financial Officer |
| Ms. Kimberly Parker J.D. | Executive VP & General Counsel |
| Mr. Brant Schofield | Executive Vice President of Corporate Development |
| Ms. Erinn Nathaniel | Director of Global Human Resources |
| Mr. Daniel Moore | Executive Vice President of Commercial |
| Dr. Frank Casty M.D. | Executive VP & Global Chief Medical Officer |
| Mr. Brenton Walter | Financial Controller |
| Ms. Laura Loftus | Associate General Counsel & Company Secretary |
Exchange: F
Country: DE : Germany
Currency: Euro (€)
| GIC Sector: | Health Care |
|---|---|
| GIC Group: | Pharmaceuticals, Biotechnology & Life Sciences |
| GIC Industry: | Pharmaceuticals |
| GIC Sub-Industry: | Pharmaceuticals |
| Forward PE: | 222.2222 |
|---|---|
| Trailing PE: | 0 |
| Price-to-Book MRQ: | 0.8984 |
| Price-to-Sales TTM: | 0.6603 |
| IPO Date: | |
| Fiscal Year End: | June |
| Full Time Employees: | 0 |